🇺🇸 FDA
Patent

US 9090933

Cancer screening by detection of ultrastructural and molecular markers

granted A61PA61P35/00

Quick answer

US patent 9090933 (Cancer screening by detection of ultrastructural and molecular markers) held by Northwestern University expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00